Journals
Publish with us
Publishing partnerships
About us
Blog
Advances in Pharmaceutics
Table of Contents
Advances in Pharmaceutics
/
2015
/
Article
/
Tab 1
/
Research Article
Formulation Development of Mouth Dissolving Film of Etoricoxib for Pain Management
Table 1
Formulation of etoricoxib MDF.
Batch code
EF-1
EF-2
S. number
Ingredients
Quantity/film
1.
Etoricoxib-beta-cyclodextrin complex
426.7 m
886.4 m
2.
Hypromellose (hydroxypropyl methyl cellulose 15 cPs)
150 mg
150 mg
3.
Sucralose
50 mg
50 mg
4.
Mixed fruit flavour 148691
0.025 mL
0.025 mL
5.
Bitter masking flavour 689796
0.025 mL
0.025 mL
6.
Glycerin
65 mg
65 mg
7.
Distilled water
5 mL
5 mL
Quantity equivalent to 30 mg of etoricoxib in single dose MDF. EF-1-MDF with beta-cyclodextrin inclusion complex (1 : 1 g ratio). EF-2-MDF with beta-cyclodextrin inclusion complex (1 : 1 molar ratio).